Clinical Trial Update: High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating high-dose chemotherapy as second-line therapy for relapsed germ cell tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor

Snippet

Sponsor: N.N. Petrov National Medical Research Center of Oncology | Conditions: Germ Cell Tumor | Phase 2 | Status: RECRUITING